Two monoclonal antibodies against fixative-modified taurine, Tau 1 and Tau2, were produced, characterized, and used in the present study to analyze the distribution of taurine in the cerebellum of the rat. In addition, immunohistochemical colocalization experiments were performed to determine whether cerebellar neurons contain both taurine and its synthesizing enzyme, cysteine sulfinic acid decarboxylase (CSADC). In ELlSAs, both Taul and Tau2 displayed high affinities for taurine conjugated to various carrier proteins and possessed some cross-reactivity for other amino acids which are present in lower concentrations in the brain than taurine. TauP was found to recognize only taurine and hypotaurine when paraformaldehyde was used to fix the amino acids to carrier proteins. With the use of glutaraldehyde fixation, Taul cross-reacted with conjugates of beta-alanine and hypotaurine and Tau2 cross-reacted strongly with conjugates of cysteic acid and hypotaurine and weakly with cysteine sulfinic acid. Despite different cross-reactivities, Taul and Tau2 exhibited almost identical patterns of neuronal staining in bands of Purkinje cells in the cerebellum. Staining of Purkinje cell dendrites was more prominent than staining of the soma. Light immunoreactivity was present in Golgi, stellate, and basket cells. A scattered population of granule cells displayed taurine-like immunoreactivity at the electron microscopic level. lmmunostaining was identified in some terminals in the Purkinje cell layer and in a limited number of mossy fibers. TauS-like immunoreactivity was colocalized with CSADC-like immunoreactivity in the cerebellar neurons described above. These immunoreactive cells may represent a subpopulation of neurons that contain a higher concentration of taurine than neighboring cells due to their ability to synthesize taurine. The intense immunoreactive staining of Purkinje cell dendrites provides support for the hypothesis that calcium-dependent release of taurine in the cerebellum may originate primarily from dendritic rather than synaptic processes and suggests a neuromodulator role for taurine in the cerebellum.
Taurine is an abundant amino acid in the mammalian CNS (Huxtable and Sebring, 1986) . Although it is present in high concentrations, taurine exhibits a slight differential distribution in the brain. Higher concentrations have been reported in cerebrum, cerebellum, and hippocampus compared with brain stem or spinal cord (Agrawal et al., 197 1; Lombardini, 1976; Palkovits et al., 1986) . Within the cerebellum, differences in taurine concentrations also exist between different cell layers, with the molecular and Purkinje cell layers containing higher concentrations of tam-me than the granule cell layer or white matter (Nadi et al., 1977; McBride and Frederickson, 1980) . These differential distributions imply that taurine may have a functional role in the CNS, in general, and within the cerebellum, in particular. There is evidence suggesting that taurine can function as a neurotransmitter (Oja and Lahdesmaki, 1974; Frederickson et al., 1978; McBride and Frederickson, 1980 ) a neuromodulator (Izumi et al., 1978; Oja, 1978, 1983; Oja and Kontro, 1978; Kuriyama, 1980) , and a stabilizer of excitable membranes @chaffer Hastings et al., 1985) .
Taurine satifies several of the criteria for classification as a neurotransmitter and/or neuromodulator in the mammalian cerebellum. Taurine produces a hyperpolarization of neurons in the cerebellum (McBride and Frederickson, 1980; Yeh et al., 198 1; Okamoto et al., 1983a-c) , including a majority of, but not all, Purkinje cells (Frederickson et al., 1978) . This hyperpolarization is associated with an increased chloride conductance (Okamoto et al., 1983b) . Electrically stimulated, calciumdependent release of taurine from cerebellar slices has been demonstrated (Bemardi et al., 1978) . Cerebellar neurons have the ability to accumulate tritiated taurine (Assumpcao et al., 1979; Chan-Palay et al., 1982a) , and rat brain synaptosomes have been shown to take up taurine in a sodium-dependent, high-affinity manner (Meiner et al., 1980) . The synergistic effects of taurine and GABA on cerebellar neurons suggest the presence of a receptor for taurine that is distinct from the GABA receptor (Frederickson et al., 1978) . A taurine antagonist, TAG (6-aminomethyl-3-methyl-4H, 1,2,4-benzothiadiazine-1,l -dioxide), has been identified (Yarborough et al., 1981) and shown to selectively antagonize the effect of taurine on Purkinje cell dendrites (Okamoto et al., 1983~) . The selective nature of this antagonist, however, has been questioned in studies of the spinal cord (Curtis et al., 1982) . Changes in taurine concentration occur in dominantly inherited cerebellar atrophies such as olivopontocerebellar atrophy (Perry, 1978) and may be significant in Friedreich's ataxia (Barbeau et al., 1982) . Several studies suggest that taurine et al. -Taurine and CSADC Colocalization i n Rat Cerebellum may be used by stellate interneurons in the cerebellum as a neurotransmitter (Nadi et al., 1977; Frederickson et al., 1978; McBride and Frederickson, 1980; Okamoto and Sakai, 1980; Okamoto et al., 1983~) . sera raised against taurine conjugated to carrier proteins. They Until recently, immunohistochemical localization of taurine within neurons and terminals was hampered by the lack of a specific marker. Wu (1982) prepared and characterized a polyclonal antiserum specific for purified bovine cysteine sulfrnic acid decarboxylase (CSADC), an enzyme involved in the metabolism of taurine. CSADC-like immunoreactivity was found to be present in sagittal microbands within the cerebellar cortex.
The CSADC antibody labels Purkinje, stellate, basket, and Golgi cells within these microzones (Chan-Palay et al., 1982a, b; Wu et al., 1986) . Neurons within the deep cerebellar nuclei are also labeled with CSADC antiserum. Several groups Campistron et al., 1986; Tomida and Kimura, 1987) have recently produced and characterized 3 separate polyclonal antiWells were washed 3 times with PBS (0.1 M, pH 7.2) containing 0.05% Tween 20 (Sigma, St. Louis) between each incubation step of this procedure, unless otherwise noted. Amino acids, at various concentrations in PBS, were incubated in the wells with either 5% glutaraldehyde or with a mixture of 0.2 M Sorensons buffer (DH 7.2) and PBS with 4% parafonnaldehyde. Plates were blocked wzh 1% BSA for 1 hr. One hundred microliters of culture supematant or ascitic fluid in PBS were incubated for 1.5 hr in the wells. The indirect immunoperoxidase or avidin-biotin staining methods were used to quantify immunoreactivity.
For the indirect-immunoperoxidase ELISA, 100 ~1 of peroxidaselabeled, goat anti-mouse antiserum (Boehringer Mannheim, Indianapolis, IN), diluted 1: 1000 in PBS, was incubated in the wells for 1 hr. Antibody labeling in the wells was visualized by reaction with o-phenylenediamine (5 mg12.5 ml, Sigma) in citrate buffer (0.03 M, pH 5) containing hydrogen peroxide (50 ~1 of 3% H,0,/12.5 ml). The absorbance of each well was read at 490 nm.
times with PBS and substrate-chromagen was added as above. AbsorFor the avidin-biotin ELISA, 100 ~1 of biotinylated anti-mouse antibody (Vectastain ABC, Vector Labs, Burlingame, CA), diluted 1:l from the kit concentration in PBS, was added to the wells and incubated for 0.5 hr. Avidin-biotin complex (100 ~11; ABC) was diluted 1: 1 in PBS, added to the wells. and incubated for 0.5 hr. The wells were washed 6 report the presence of tam-me-like immunoreactivity in essentially all Purkinje cells throughout the cerebellar cortex and rarely in stellate and basket cells. Yoshida and coworkers (1986) , however, reported staining of many, but not all, Purkinje cells with a different oolvclonal taurine antiserum.
In the present study, we developed and characterized 2 monoclonal antibodies against taurine conjugated to keyhole limpet hemocyanin (IUH) and report the immunohistochemical localization of taurine in the cerebellum of the rat. Taurine immunostaining was examined using light and electron microscopy and the distribution of tam-me-like immunoreactivity was comDared with that obtained bv others usine. nolvclonal tam-me bance was quantified at 490 nm.
Antibody afinityforfuced amino acids evaluated by inhibition ELBA.
Conjugates of amino acids fixed to carrier protein were made by reacting 20 mg of carrier protein with 0.2 18 mmol of amino acid in 6 ml of PBS at DH 7.2 for 1 hr in 5% elutaraldehvde followed bv dialysis in PBS. Antibodies were meincubated for at least 1.5 hr with these amino acid conjugates before use in inhibition ELISA assays. Either the indirect immunoperoxidase or the ABC ELISA was then carried out as described above on plates coated overnight with 2 &ml of TauKLH at room temperature. The ratios of the concentrations of amino acid conjugates Droducine 50% of the uninhibited ELISA reactivitv were used to calculate the percent cross-reactivity of the antibodies for the amino acids. for CSADC-like immunoreactivity and Yoshida et al. (1986) previously described (Wu, 1982) . Rats were anesthetized with chloral for taurine-like immunoreactivity. In addition, double-labeling hydrate and sacrificed by transcardial perfusion with 100 ml calciumstudies demonstrated that taurine-like immunoreactivity was free Tyrode's solution followed by 450 ml of one of 3 fixatives: 4% colocalized with CSADC-like immunoreactivity in cerebellar paraformaldehyde (Tau2 and Tau2ICSADC), 4% paraformaldehyde/ 0.2-0.4% elutaraldehvde (Taul, Tau2, and CSADC), or 5% glutaralneurons.
dehyde (Taul and Tau2). Brains were removed and postfixed overnight in the same fixative with which thev were nerfused.
Materials and Methods Antibody production and characterization
Brains were sectioned (30-50 prnj in the-coronal or horizontal plane with the use of a Vibratome. Free-floating sections were processed with the Vectastain avidin-biotin-neroxidase method (Vector Labs, Burlingame, CA) as follows, with 3*rinses in PBS following each incubation step. Adjacent tissue sections were incubated overnight with 1 of 3 primary antibodies, diluted in PBS + 0.3% Triton, and either normal horse serum (Taul and Tau2) or normal goat serum (CSADC). Optimum primary antibody dilutions (dilution ranges in parenthesis) were as follows: Tau2 culture supematant, 1:640 (1:40-1:640), Taul culture supematant, 1:lOO (1:40-1:640), or CSADC antiserum, 1:400 (1:400-1: 1000). Sections were incubated for 1 hr in secondary biotinylated antibody diluted 1:4 in PBS and 1 hr in avidin-biotin-peroxidase complex (ABC) diluted 1:4 in PBS. Sections were reacted with diaminobenzidine (DAB) and hydrogen peroxide to produce a brown homogeneous reaction product.
Adiacent 50 urn sections stained with either Tau2, Taul, or CSADC Production of monoclonal antibodies. The original immunogen for this study was produced by conjugating taurine to keyhole limpet hemocyanin (KLH) with the use of glutaraldehyde-borohydride (Mad1 et al., 1986) . Male Balb/c/umc mice were immunized over a 4 week period and snleen cells from these mice were fused with P3x63-Ag8.653 myeloma cells as previously described (Mad1 et al., 1987) . Cuiture supematants from wells containing fused cells were screened for reactivity with the original immunogen using. enzyme-linked immunosorbent assay (ELISAJ (Mad1 et al.,-1986) . Cell lines producing supematants, which had ELISA reactivity for taurine/IUH but not KLH treated with glutaraldehyde-borohydride, were examined for immunocytochemical staining of brain sections. Two cell lines, Taul and Tau2, were found to produce antibodies capable of tissue staining and also possessed ELISA reactivity for the original immunogen but not the carrier protein. These 2 cell lines were subcloned by limiting dilution and the antibodies produced were isotyped using the mouse monoclonal antibody subisotyping kit from Hyclone Laboratories (Logan, UT). Ascites fluid from these 2 cell lines was produced in pristane-primed mice as previously described (Mad1 et al., 1986) .
were compared at the light microscopic level for similarity of staining. The location of stained Purkinje cell perikarya was mapped with the use of a camera lucida attachment on an Olympus microscope.
Tissue from 16 rats was processed for electron microscopic immunohistochemical localization of taurine. Animals for electron microscopy were anesthetized with chloral hydrate and perfused sequentially with 100 ml of calcium-free Tyrode's solution and 450 ml of 4% paraformaldehyde and 0.3% glutaraldehyde. Tissue sections were processed as for light microscopy, except that Triton-X100 was not used in any of the incubating solutions. Following visualization of the taurine antibody complex with DAB and hydrogen peroxide, tissue sections were thoroughly rinsed in PBS, immersed for 1 hr in buffered 2% osmium teAntibody reactivity for Jixed small molecules. Fixation of small molecules and subsequent immunoreactivity was tested and quantified using ELISA systems that model the fixation and immunoreactivity of these molecules in tissue. Immulonl ELISA mates (Fisher Scientific. Minneapolis, MN) were coated with 10 &ml of thyroglobulin in 0.05 M bicarbonate buffer (pH 9.6, 100 &well) overnight at room temperature. troxide, rinsed in PBS, and dehydrated in a graded series of ethanol solutions. Tissue sections were infiltrated with either Polybed 8 12 or Spurr resin (Polysciences, Wanington, PA) and embedded between glass slides coated with dichlorodimethylsilane.
Polymerized tissue sections were examined with light microscopy, and areas of interest were scribed, mounted on blocks, and sectioned. All thin sections were examined unstained at 40 kV on a Zeiss 10 EM.
Colocalization studies
Eleven male Sprague-Dawley rats were used for colocalization studies. Rats were perfused, as above, with 4% paraformaldehyde. Sections used for double-labeling studies were incubated with either the Tau2 (1:640) or CSADC (1:400) antisera overnight and processed as described above, with the exception that the secondary biotinylated antibody and ABC were diluted 1:8 in PBS. The DAB reaction was followed by an avidinbiotin blocking step to prevent cross-reactivity between markers. Tissue was incubated for 20 min in excess avidin, rinsed with PBS, incubated in excess biotin for 20 min, and rinsed with PBS. Tissue sections were incubated overnight in normal serum (see above) and the alternate primary antibody. Sections were incubated, as above, in biotinylated secondary antibody and ABC. Benzidine dihydrochloride (BDHC) was used as the chromagen for the second marker to produce a blue granular reaction product. The BDHC procedure was modified from Lakos and Basbaum (1986) and Sugimoto et al. (1985) .
Briefly, sections were prewashed in 0.1 M sodium acetate buffer (pH 6.5). Four solutions were prepared: 1, BDHC (20 mg) dissolved in 18 ml ethanol (100%) and 40 ml distilled water, with heat to ~40°C to dissolve; 2, sodium nitroprusside (62.5 mg/3 ml H,O); 3, sodium acetate buffer (0.2 M, pH 6.5); and 4, 3% H,O,.
The suggested ratio of solutions is as follows: 3.75 ml of solution 1, 50 ~1 of solution 2,600 ~1 of solution 3, and 15 ~1 of solution 4. Optimum BDHC incubation time was 5 min with Tau2 antibody and 4 min with CSADC antiserum. The BDHC reaction was stopped by excess sodium acetate buffer (0.1 M) and subsequent rinses in PBS. Sections were examined at the light microscopic level for the presence of brown homogeneous DAB reaction product and blue granular BDHC reaction product within cells and processes, which indicated colocalization. Controls for the colocalization studies included the following: absorption controls of Tau2 with 1 m&ml of original KLH conjugates (taurine conjugated to IUH) for both the DAB and BDHC reactions, Tau2 and CSADC as first markers on adjacent sections to compare similarity of DAB staining, elimination of either the Tau2 or CSADC primary antisera, or both, to rule out cross-reactivity caused by ABC components.
Results

Antibody characterization
All characterizations of the monoclonal antibody specificities and cross-reactivities were done on amino acids fixed to thyroglobulin or KLH with either glutaraldehyde, paraformaldehyde, or both. Neither antibody displayed reactivity for carrier proteins, KLH or thyroglobulin, treated with glutaraldehydeborohydride in the absence of amino acids. Both monoclonal antibodies to taurine, Taul and Tau2, were found to possess strong ELISA reactivity for taurine and weaker reactivity for hypotaurine, fixed to thyroglobulin with glutaraldehyde (Fig.   1A ). In addition, Taul , but not Tau2, also displayed weak immunoreactivity for beta-alanine fixed to thyroglobulin using glutaraldehyde but almost no detectable immunoreactivity for other fixed amino acids ( Concentration of InAFbiting &njugaii (pg K&ml) Figure 2 . Inhibition of Tau 1 and Tau2 ELISA reactivity for taurinel KLH by amino acids conjugated to KLH with the use of glutaraldehyde. Each point represents the mean percentage of avidin-biotin ELISA reactivity in 3 replicate wells after preincubation of Taul and Tau2 with conjugates of amino acids. SEs were 5% or less for the replicate wells. Tau/KLH was coated on the ELISA plates at 2 &ml. A, Taul culture supematant was used at a 1:40 dilution in the assay. B, Tau2 ascitic fluid was used at a 1: 1000 dilution in the assay.
ELISA reactivity for cysteic acid fixed with glutaraldehyde ( Fig.  lB) , in addition to its strong ELISA reactivity for taurine and hypotaurine. Other amino acids were not strongly reactive with Tau2 in this assay (Table 1) . Similar results were obtained with the use of 4% paraformaldehyde-O.3% glutaraldehyde (not shown). In order to quantify the cross-reactivity of the antibodies for fixed amino acids, competitive inhibition ELISAs were performed (Fig. 2) . The cross-reactivities for various amino acids were different for the 2 antibodies (Table 2) . Taul had 10% cross-reactivity for beta-alanine and less than 2% cross-reactivity for other amino acids in the brain, such as glutamate, GABA, cysteic acid, and cysteine sulfinate when conjugated with glutaraldehyde. Tau2 had no detectable cross-reactivity for betaalanine fixed with glutaraldehyde but had higher binding to cysteic acid conjugates than for taurine conjugates and a weaker cross-reactivity for cysteine sulfinate conjugates. The only glutaraldehyde-fixed amino acids shown to have measurable immunoreactivity for both Taul and Tau2 were taurine and hypotaurine.
In contrast, when paraformaldehyde was used to fix the amino acids to thyroglobulin for ELISAs, Tau2 was found to have strong immunoreactiivty for taurine and hypotaurine conjugates but not for conjugates of cysteic acid, cysteine sulfinate, or other Q Cross-reactivities, expressed as percentage, were determined from the ratio of the concentration ofconjugate ofan amino acid that inhibited the ELBA reactivity to 0.5 of the uninhibited value to the concentration of the taurine conjugate that inhibited the ELISA to 0.5 of the uninhibited reactivity. D ELISAs were performed using the indirect immunoperoxidase method. At least 3 replicate wells for each concentration of conjugate were used to determine the degree of inhibition. amino acids tested (Fig. 3, Table 3 ). Taul was not immunoreactive with any amino acids tested in ELISAs fixed with paraformaldehyde alone, i.e., without any glutaraldehyde.
Immunohistochemical localization of taurine Taurine-like immunoreactivity (Tau-LI) with Tau2 in the cerebellum of rats perfused with 4% paraformaldehyde was present in a subpopulation of Purkinje cells (Fig. 4A ). These bands of immunoreactive cells, and their dendrites, were separated by bands of unstained Purkinje cells (Fig. 4, A, B) . This pattern of stained Purkinje cells was present in both the vermis and hemispheres of the cerebellum. Very light Tau-LI appeared to be present in Golgi, stellate, and basket cells at the light microscopic level (see Fig. 9 , C-E). Tau-LI was completely absorbed by incubation of Tau2 antibody with the original antigen, taurine conjugated to IUH with glutaraldehyde-borohydride (Fig. 4, C,  0) . Tau2 demonstrated no cross-reactivity for the original carrier protein without taurine in ELISAs.
Bands of stained Purkinje perikarya and dendrites were also present in the cerebellum of rats perfused with a 4% paraformaldehydeglutaraldehyde (0.2-0.4%) solution and reacted with either Taul or Tau2 (Fig. 5) . Occasionally, with both paraformaldehyde-glutaraldehyde and paraformaldehyde alone, only bands of stained Purkinje cell dendrites were present with no staining of associated Purkinje cell somata (Fig. 5C ). The opposite was not seen, immunoreactive Purkinje cell somata were always associated with immunoreactive dendrites. Light microscopic observation and camera lucida mapping demonstrated that immunoreactivity produced by Taul and Tau2 appeared to be present in almost identical patterns of Purkinje cells on adjacent 50 pm sections (Fig. 5) .
Tau-LI was more noticeable in Golgi, stellate, and basket cells fixed with paraformaldehyde-glutaraldehyde than with paraformaldehyde alone, although the staining intensity was still lighter than that present in the Purkinje cells. Examination of tissue sections at the electron microscopic level confirmed the observation that many of the stellate and basket cells contained Tau-LI (Fig. 6, A, B) . Granule cells appeared to be nonimmunoreactive for both Tau2 and Taul at the light microscopic level, but a subpopulation exhibited Tau-LI at the electron microscopic level (Fig. 6C) . In general, though, few immunoreactive granule cells were seen, and those that were stained tended to occur in discrete patches. Tau-LI was also present in some mossy fibers (Fig. 7A ) and in a small number of axon terminals that synapscd on basket cells (Fig. 7B ) and Purkinje cells (not shown). Immunoreactive stellate and basket cells were not confined to the bands of Purkinje staining but appeared to be evenly distributed within their respective cerebellar layers at both the light and electron microscopic levels.
In general, with the use of 5% glutaraldehyde fixation, immunorcactive staining with either Tau 1 or Tau2 was present in the majority of Purkinje cells. Occasional unstained Purkinje perikarya were noted. Golgi, stcllate, and basket cells were also stained with this fixation protocol, although, again the staining was lighter than in Purkinje cells. Taul and Tau2 immunoreactive staining obtained with each of the 3 fixation protocols was absorbed out by incubation with the original antigen.
Colocalization
Tau2 and CSADC antisera displayed similar staining patterns in a subpopulation of Purkinje cells on 50 I.trn adjacent sections. The lack of total agreement in staining between the 2 antisera appeared to be a limitation of the use of 50 pm sections. In order to confirm that the same neurons were stained by both antisera, colocalization studies were conducted using the ABC technique and 2 different chromagens, DAB and BDHC. Double-labeling of sections with Tau2 and CSADC produced colocalization in the majority of immunoreactive neurons present, including Purkinje, Golgi, stellate, and basket cells (Figs. 8,  9 ). The labeling of the latter 3 cell types was more apparent in paraformaldehyde-fixed tissue on double-labeled sections than on single-labeled sections with DAB alone because of clustering of blue BDHC granules over the light DAB reaction (Fig. 9, C ( Fig. 9n ) unfortunately is more easily discernible with color microscopy than with black-and-white photography.
In the 11 animals studied, less than 10% of DAB-stained neurons did not contain any perceptible evidence of BDHC. However, BDHC was always the second marker in the doublclabeling studies, and Tau2/BDHC and CSADUBDHC reactions were less dense on double-labeled sections compared with single-labeled sections stained with Tau2/BDHC or CSADC/ BDHC alone. This effect of double-labeling was more noticeable with Tau2 as the second marker than with CSADC. The BDHC reaction product was only found to be clustered in neurons that were also labeled with the DAB reaction product. BDHC granules were found over the white matter and were sparsely located in the granule cell layer (Fig. 90 . Tau-LI, visualized with DAB, has been identified in some axons in cerebellar white matter at the electron microscopic level (unpublished observations).
Sections stained only for CSADUDAB, adjacent to doublelabeled sections with Tau2/DAB-CSADUBDHC, exhibited an identical staining pattern to the Tau2/DAB and CSADUBDHC (Fig. 8) . The same was true for sections stained only for TauU DAB and sections double-labeled with CSADUDAB-Tau2/ BDHC. This finding, along with a lack of BDHC granules on control sections in which the primary antibody was omitted from the ABC-BDHC procedure, ruled out the possibility that the BDHC was binding nonspecifically to the DAB reaction product. There was no staining of sections with either DAB or BDHC when associated primary antibodies were omitted. Tau2 
Discussion
This study describes the production of 2 monoclonal antibodies, Tau 1 and Tau2, which were highly selective for aldehyde-fixed taurine and which, despite different cross-reactivities in ELISAs for small molecules similar to taurine, exhibited identical immunohistochemical staining patterns in the cerebellum of the rat. The Taul and Tau2 antibodies also displayed a similar staining pattern to that obtained using antiserum against an enzyme marker for taurine-containing neurons, CSADC. Indeed, we have shown in the present study that Tau2 and CSADC immunoreactivities are colocalized in Purkinje, Golgi, stellate, and basket cells of the rat cerebellum. Tau2 and CSADC also have been colocalized in neurons within the hippocampus (Magnusson et al., 1987) .
Tau2 displayed cross-reactivity for both cysteic acid (CA) and cysteine sulfinic acid (CSA) when glutaraldehyde or paraformaldehyde-glutaraldehyde fixation was used. This problem was circumvented, in the majority of experiments presented in this study, by fixing the brain tissue with paraformaldehyde alone.
Tau2 shows little or no cross-reactivity for CA or CSA in ELlSAs with paraformaldehyde alone. t On adjacent 50 pm thick brain sections fixed with paraformaldehyde-glutaraldehyde, Taul and Tau2 exhibited almost identical staining patterns (Fig. 5) , despite the differences in cross-reactivities between the 2 antibodies in ELISAs. The lack of total agreement of staining between the 2 antibodies is probably a limitation of the use of 50 pm sections. Taul exhibited much lower cross-reactivity for CA or CSA conjugates than did Tau2, and Tau2 had a much lower cross-reactivity with betaalanine conjugates than did Tau 1. The low concentration of CA and CSA in the rat brain, compared with taurine, would suggest that CA and CSA probably constitute a very minor proportion of Tau2 antibody binding in glutaraldehyde-fixed rat brain. Kuriyama and coworkers (1986) reported that the amount of CSA and CA in the cerebellum of Wistar Kyoto rats is 27.5 and 11.6 nmol/gm wet weight, respectively. Taurine levels in the cerebellum are 4.7 rmol/gm wet weight, a 200-to 400-fold difference in concentration. Comparable differences in concentrations of these amino acids occur in other brain regions (Kuriyama et al., 1986) . Based on the comparison of Tau2 immunostaining with Tau 1 immunostaining and the tissue concentration differences, we conclude that either CA and CSA concentrations were too low to be detected by Tau2 in this study or the CA and/or CSA labeled by Tau2 were present in the same neurons as taurine, where they may serve as precursors for taurine. Chan- Palay and coworkers (1982b) were the first to describe the presence of CSADC-like immunoreactivity, a proposed marker for tam-me-containing neurons, in sagittal microbands in the cerebellum. They reported staining in Purkinje, Golgi, stellate, and basket cells. The similarity of staining of Taul and Tau2 in the cerebellum to that reported by Chan-Palay et al. (1982b) led us to attempt to colocalize the 2 proposed taurinergic cell markers. Tau2 and CSADC antisera were found to be colocalized within neurons of the rat cerebellum. The lack of total colocalization appeared to be a limitation of the double-labeling technique. The BDHC reaction product uniformly appeared less dense on double-labeled sections than on sections labeled with BDHC alone. This suggests that the first primary antibody, ABC complex and/or DAB reaction interfered with binding of the second primary antibody by covering antigenic sites. This interference may have caused the total absence of BDHC granules on some DAB-labeled cells that might have been present in the absence of the first antibody/DAB complex. Given this limitation, the lack of clustering of Tau2/BDHC or CSADUBDHC reaction product over neurons without DAB staining supports the conclusion that the 2 markers are colocalized within neurons of the cerebellum. The results of the controls performed ruled out nonspecific cross-reactivity between the 2 markers in the colocalization studies.
Several groups Campistron et al., 1986; Tomida and Kimura, 1987) , with the use of glutaraldehyde fixation, reported taurine-like immunoreactivity in all, or a majority of, Purkinje cells and in few Golgi, stellate, and basket cells of the rat cerebellum. The tissue in which we report the presence of immunostained Purkinje cell bands was fixed with either paraformaldehyde or paraformaldehyde-glutaraldehyde. On tissue fixed with 5% glutaraldehyde, Taul and Tau2 stained the majority of Purkinje cell perikarya and dendrites. Thus, our results with glutaraldehyde-fixed tissue were similar to that reported by others Campistron et al., 1986; Tomida and Kimura, 1987) . Tau-LI, obtained with Taul or Tau2, also was present in Golgi, stellate, and basket cells. These neurons, however, were stained more lightly than the Purkinje cells and only represent a subpopulation of their total respective populations. Yoshida et al. (1986) mentioned the presence of weak, or unstained, Purkinje cells among the stained Purkinje cells with the use of paraformaldehyde-glutaraldehyde fixed tissue. This is similar to our staining with paraformaldehyde and paraformaldehyde-glutaraldehyde.
Glutaraldehyde is a more efficient fixative for amino acids than is paraformaldehyde (Ottersen et al., 1985) . However, we were able to measure immunoreactivity for taurine and hypotaurine fixed to carrier proteins with paraformaldehyde in ELISAs (Fig. 3) . It is possible that, with a less effective fixative such as paraformaldehyde, only those neurons containing a higher concentration of tam-me were stained with an equivalent intensity. The colocalization studies indicate that this subpopulation of neurons, with Tau-LI, also contain the CSADC enzyme and might therefore contain a higher concentration oftaurine because oftheir ability to synthesize this amino acid. It has been demonstrated that fixation of certain amino acids can be hindered by the presence of other amino acids . It is possible that the unstained Purkinje cells observed in paraformaldehyde-fixed tissue contained a higher concentration of other amino acids, such as GABA, which interfered with the fixation of taurine. However, the presence of colocalized CSADC in neurons stained with Tau-LI suggests that this is a unique subpopulation of Purkinje cells.
The significance of the bands of Purkinje cells containing Tau-LI and CSADC-LI is, as yet, unknown (Chan-Palay et al., 1982b) . A banded staining pattern with both antisera was also present in tissue that was immersion fixed with 4% paraformaldehyde (unpublished observations). This would argue against the bands being merely a result of variations in fixation during perfusion. Previous reports have identified similar subpopulations of cerebellar Purkinje cells containing GABA and/or motilin (ChanPalay et al., 1981; Chan-Palay, 1983) or bands of Purkinje cells positively and negatively stained with monoclonal antibodies raised against a component of a cerebellar homogenate (Hawkes et al., 1985) . Longitudinal patterns of climbing fiber projections (Groenewegen and Voogd, 1976; Oscarsson, 1976; Voogd et al., 1985; Logan and Robertson, 1986; Robertson and Logan, 1986) , mossy fiber projections (Oscarsson, 1976; Voogd et al., 1985) Purkinje cell axons (Feirbend et al., 1976) , and acetylcholinesterase (Hess and Voogd, 1986; Robertson and Logan, 1986) , and cytochrome oxidase (Hess and Voogd, 1986 ) localizations exist in the cerebellum. The relationship between the subpopulation of taurine neurons identified in this study and other longitudinal cerebellar patterns remains to be determined.
Studies have suggested that taurine acts as a neurotransmitter for stellate intemeurons in the cerebellum (Nadi et al., 1977; Frederickson et al., 1978; McBride and Frederickson, 1980; Okamoto and Sakai, 1980; Okamoto et al., 1983a-c) . Some anatomical studies report tritiated taurine uptake into cerebellar intemeurons (Chan-Palay et al., 1982a) and CSADC-LI in the same intemeurons; i.e., Golgi, stellate, and basket cells (ChanPalay et al., 1982a, b) . Assumpcao and coworkers (1979) however, reported tritiated tam-me uptake into Purkinje cells and dendrites but not in interneurons. The majority of taurine immunohistochemistry studies report weak or no staining of cerebellar stellate and basket cells Campistron et al., 1986; Yoshida et al., 1986; Tomida and Kimura, 1987) . Our antibodies stained these cells lightly. Madsen et al. (1985) reported no evidence of Tau-LI in nerve terminals in the molecular layer, and Yoshida et al. (1986) reported a lack of basket cell terminals containing Tau-LI. These reports, therefore, do not support the theory of tam-me acting as a major neurotransmitter for stellate or basket cells.
In the present study, Tau-LI was present in some mossy fibers and in some terminals that synapsed on Purkinje cells and basket cells. These results may provide evidence for a neurotransmitter role of taurine in the cerebellum; however, taurine has been shown to modulate the synaptic release of transmitters such as ACh, norepinephrine, and GABA (Kuriyama, 1980) . Researchers have proposed that some mossy fibers use the excitatory amino acid glutamate as a neurotransmitter (Freeman et al., 1983; Beitz et al., 1986; Somogyi et al., 1986; Wenthold et al., 1986) . We believe that taurine is more likely to serve in a neuromodulatory role in these excitatory fibers than in a classical transmitter role.
Taurine is more effective at causing hyperpolarization on the Purkinje cell dendrite than on the soma (Frederickson et al., 1978; Okamoto and Sakai, 1980; Okamoto et al., 1983a, b) . Calcium is the ion primarily responsible for dendritic excitability in Purkinje cells (Llinb and Sugimori, 1980) . Taurine reportedly blocks dendritic calcium spikes by preventing further influx of calcium into the dendrite (Okamoto et al., 1983a ).
-Taurine release in the cerebellum also has been demonstrated to be calcium dependent (Bernardi et al., 1977 (Bernardi et al., , 1978 . In our study, the presence of Tau-LI was most prominent in Purkinje cell dendrites, followed by the soma, and light Tau-LI in cerebellar interneurons. Nonsynaptic release of taurine has been shown in hippocampus (Lehmann et al., 1986) and optic nerve (Kuriyama, 1980) . The electrically stimulated, calcium-dependent release of taurine in cerebellar slices (Bemardi et al., 1978) could, therefore, be due to release of taurine from the postsynaptic Purkinje cell dendrite in response to a calcium-linked depolarization, as has been described in pyramidal cell dendrites with N-methyl-D-aspartate (Lehmann et al., 1985) . Taurineinduced hyperpolarization of Purkinje cell dendrites, which has been attributed to the release of taurine by stellate cells, may be caused by calcium-stimulated release of taurine from the postsynaptic Purkinje cell dendrite in a negative-feedback mechanism. The released tam-me would then function to modulate further influx of calcium and control the excitability of the cell.
In summary, Taul and Tauf, monoclonal antibodies with high affinity for aldehyde-fixed taurine, exhibit almost identical immunoreactive staining patterns in a subpopulation of Purkinje cell dendrites and soma and light immunoreactivity within Golgi, stellate, and basket cells. These neurons containing Tau-LI also contain the enzyme CSADC, suggesting that this subpopulation of neurons can produce taurine. Prominent Purkinje cell dendritic staining and lack of numerous terminals in the molecular layer provide anatomical evidence to suggest that the calcium-linked depolarization of Purkinje dendrites may cause a release of taurine from the dendrites, which then functions to prevent further depolarization. Thus, the results of this study suggest a neuromodulator role for taurine in the cerebellum.
